Table 1 Clinical characteristics of the 28 breast tumours included in the study
n | % of total | Tumours with increased LRIG1 copy number (n = 11) | Tumours without increased LRIG1 copy number (n = 17) | |
|---|---|---|---|---|
Tumour type | ||||
Ductal | 21 | 75 | 10 (82 %) | 11(65%) |
Lobular | 2 | 7 | 1 | 1 |
Mixed group | 4 | 14 | 0 | 4 |
Medullar | 1 | 4 | 0 | 1 |
Axillar lymph node | ||||
Negative | 17 | 61 | 6 (54%) | 11 (65%) |
Positive | 10 | 36 | 5 (45%) | 5 (29%) |
Missing value | 1 | 4 | 0 | 1 |
Estrogen receptor | ||||
Positive | 21 | 75 | 8 (73%) | 13 (76%) |
Negative | 4 | 14 | 2 (9%) | 2 (12%) |
Missing value | 3 | 11 | 1 | 2 (12%) |
Progesterone receptor | ||||
Positive | 18 | 64 | 6 (54%) | 12 (70%) |
Negative | 5 | 18 | 3 (27%) | 2 (28%) |
Missing value | 5 | 18 | 2 (18%) | 3 (18%) |
Outcome=deceased | 10 | 36 | 3 (27%) | 7 (41%) |